JILL OLEK: Open Payments
NPI 1154632685 · AMERICUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 60 payments from 17 companies in 2025. Trend: 2023 $1,726 · 2024 $1,560 · 2025 $1,116
Food & beverage: $1,116
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $171 |
| PFIZER INC. | 8 | $144 |
| Novo Nordisk Inc | 9 | $143 |
| Corcept Therapeutics | 5 | $116 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
| Dexcom, Inc. | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
Products named: TRELEGY ELLIPTA, Korlym, ELIQUIS, Wegovy, AIRSUPRA, JARDIANCE, Dexcom G6 Transmitter, CAPLYTA.
Industry payments across GA — which companies pay providers there.
